FDA Reminds Doctors: Please Don't Transplant Sepsis Into People
Published Date: 1/7/2025
Notice
Summary
The FDA just released new rules to help stop infections like sepsis from spreading through donated human cells and tissues. This affects all places that check donors before using their cells or tissues in treatments. These updated recommendations start right away and aim to keep patients safer without adding big costs or delays.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Immediate sepsis screening guidance
The FDA released a final guidance titled "Recommendations To Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)" that is available for immediate implementation as of January 7, 2025. If you make donor eligibility determinations for human cells or tissues, the guidance provides recommendations to reduce the risk of transmitting infections that cause sepsis.
Separate tuberculosis screening guidance
In the same Federal Register issue, FDA announced availability of a separate final guidance titled "Recommendations To Reduce the Risk of Transmission of Mycobacterium Tuberculosis (Mtb) by HCT/Ps" that is also for immediate implementation as of January 7, 2025. If you make donor eligibility determinations, that guidance provides recommendations for screening donors for evidence of, and risk factors for, Mtb, which can cause sepsis.
Supersedes 2007 sepsis guidance
The new guidance supersedes the sepsis-related information in the August 2007 guidance on donor eligibility for HCT/Ps. If your establishment used the August 2007 recommendations, you should review and consider the updated recommendations announced January 7, 2025.
No new paperwork burden
The guidance itself contains no new collection of information and refers to previously approved collections under OMB control number 0910-0543 for 21 CFR 1271 activities such as donor screening, testing, and recordkeeping. If you operate an HCT/P establishment, the guidance does not add new paperwork requirements beyond those already covered under OMB 0910-0543.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11283 — Notice of Availability of the Record of Decision for the Final Environmental Impact Statement for the Dakota Access Pipeline, Lake Oahe Crossing, North Dakota
The U.S. Army Corps of Engineers has officially decided to allow the Dakota Access Pipeline to cross under Lake Oahe in North Dakota, but with extra safety rules. This affects local communities, the environment, and the pipeline company, ensuring the project moves forward carefully. The decision is now public, so everyone knows the plan and what comes next.
2026-11287 — DNP Select Income Fund Inc., et al.
DNP Select Income Fund and several other investment companies want permission to pay out long-term capital gains more often—up to 12 times a year instead of just once or twice. This change could mean more frequent income for investors in these funds, starting after the SEC reviews and approves the request. If you’re interested, you have until June 29, 2026, to ask for a hearing or share your thoughts.
2026-11309 — 60-Day Notice of Proposed Information Collection: Service Coordinators in Multifamily Housing
HUD wants to collect updated info from service coordinators who help people in multifamily housing. They’re asking for public feedback over the next 60 days before finalizing the forms and rules. This helps make sure funds are used right and keeps support services running smoothly, with no new costs for those involved.
2026-11296 — Notice of Determinations and Request for Comments Concerning Actions in Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure To Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced With Forced Labor
The U.S. Trade Representative found that many countries aren’t stopping goods made with forced labor from entering the U.S. To fix this, they’re planning to add extra taxes (tariffs) on products from these countries, with rates between 10% and 12.5%. They’re also offering a special deal for some clothing imports and want your thoughts before finalizing these changes by early July 2026.
2026-11327 — Proposed Revisions to the National Handbook of Conservation Practices
The USDA’s Natural Resources Conservation Service is updating some rules in the National Handbook of Conservation Practices to help farmers and landowners protect the environment better. These changes could affect how conservation projects are planned and done, and the public can share their thoughts until July 6, 2026. No big costs are expected, but the updates aim to make conservation easier and more effective.
2026-11276 — Long Island Rail Road's Request To Amend Its Positive Train Control System
The Long Island Rail Road wants to make some changes to its safety system that helps prevent train crashes, called Positive Train Control (PTC). They asked the government for approval on May 21, 2026, and now the public can share their thoughts until June 25, 2026. These updates aim to keep trains safer without causing delays or extra costs for riders.
Previous / Next Documents
Previous: 2024-31537 — Study of Sex Differences in the Clinical Evaluation of Medical Products; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to make sure medical studies include enough women and men to spot any differences in how treatments work. This means drug makers and researchers will need to design smarter studies and share sex-specific results when they apply for approval. Comments on this draft are open until April 7, 2025, so get ready to weigh in and help shape the future of fairer medical testing!
Next: 2024-31539 — Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers; Guidance for Industry; Availability; Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request
The FDA just released final guidance on how companies can share scientific info about unapproved uses of approved medical products with health care providers. This update affects medical product firms and aims to clarify communication rules, but it won’t take effect until the Office of Management and Budget reviews the info collection by February 21, 2025. No new costs yet, but companies should get ready to follow these clearer, friendlier rules soon!